Cobas Taqman
COBAS AmpliPrep COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real Time PCR Assay for Quantification of HBV DNA in Plasma
7
Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV 1 Test and Identification of Rare Polymorphisms Potentially Affecting Assay Performance
7
Evaluation of the COBAS TaqMan HCV Test with Automated Sample Processing Using the MagNA Pure LC Instrument
6
Ability of Two Commercially Available Assays (Abbott RealTime HIV 1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV 1 Version 2 0) To Quantify Low HIV 1 RNA Levels ( Alessandra Amendola, Patrizia Marsella, Maria Bloisi, Federica Forbici, Claudio Angeletti, Maria R Capobianchi A M Caliendo, Editor
8
The Cobas AmpliPrep/Cobas TaqMan HCV Test, Version 2 0, Real Time PCR Assay Accurately Quantifies Hepatitis C Virus Genotype 4 RNA
5
Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2 0
12
Evaluation of the Cobas TaqMan MTB Test for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens
5
Second Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual Probe Assay Design
7
Evaluation of Cobas TaqMan MTB for Direct Detection of the Mycobacterium tuberculosis Complex in Comparison with Cobas Amplicor MTB
6
Performance of the Cobas AmpliPrep/Cobas TaqMan Real Time PCR Assay for Hepatitis B Virus DNA Quantification
8
Performance of Three Commercial Viral Load Assays, Versant Human Immunodeficiency Virus Type 1 (HIV 1) RNA bDNA v3 0, Cobas AmpliPrep/Cobas TaqMan HIV 1, and NucliSens HIV 1 EasyQ v1 2, Testing HIV 1 Non B Subtypes and Recombinant Variants
6
Correction of Underquantification of Human Immunodeficiency Virus Type 1 Load with the Second Version of the Roche Cobas AmpliPrep/Cobas TaqMan Assay
6
Development of a Second Version of the Cobas AmpliPrep/Cobas TaqMan Hepatitis C Virus Quantitative Test with Improved Genotype Inclusivity
7
Performance of Version 2 0 of the Cobas AmpliPrep/Cobas TaqMan Real Time PCR Assay for Hepatitis B Virus DNA Quantification
7
Performance Evaluation of the New Roche cobas AmpliPrep/cobas TaqMan HCV Test, Version 2 0, for Detection and Quantification of Hepatitis C Virus RNA
5
Performance Evaluation of the New Roche Cobas AmpliPrep/Cobas TaqMan HIV 1 Test Version 2 0 for Quantification of Human Immunodeficiency Virus Type 1 RNA
6
Comparison of the RealTime HIV 1, COBAS TaqMan 48 v1 0, Easy Q v1 2, and Versant v3 0 assays for Determination of HIV 1 Viral Loads in a Cohort of Canadian Patients with Diverse HIV Subtype Infections
7
Comparison of the Abbott RealTime Human Immunodeficiency Virus Type 1 (HIV 1) Assay to the Cobas AmpliPrep/Cobas TaqMan HIV 1 Test: Workflow, Reliability, and Direct Costs
7
Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2 0 and Versant HCV bDNA 3 0 Assays
8
Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies
8